Dalbavancin in the Treatment of Bacteremia and Endocarditis in People with Barriers to Standard Care.
Leama AjakaEmily L HeilSarah SchmalzlePublished in: Antibiotics (Basel, Switzerland) (2020)
Dalbavancin may have a role as salvage therapy in the treatment of IE and bacteremia in PWID who have significant barriers to standard treatment.